DNA methylation predicts progression of human gastric lesions

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1607-1613

  Schneider, Barbara G ^a   Mera, Robertino ^a   Piazuelo, M Blanca ^a   Bravo, Juan C ^b   Zabaleta, Jovanny ^c   Delgado, Alberto G ^a   Bravo, Luis E ^d   T wilson, Keith ^a,e   El Rifai, Wael ^a,e   Peek, Richard M ^a   Correa, Pelayo ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b FUNDACIÓN VALLE DEL LILI   (Colombia)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD DEL VALLE   (Colombia)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPH PROTEIN; ANTIOXIDANT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; EN1 PROTEIN; NKX6 1 PROTEIN; PCDH10 PROTEIN; RPRM PROTEIN; RSPO2 PROTEIN; SORCS3 PROTEIN; TRANSCRIPTION FACTOR EMX1; UNCLASSIFIED DRUG; UVOMORULIN; ZIC1 PROTEIN; ZNF610 PROTEIN; ANTIINFECTIVE AGENT; TUMOR MARKER;

ADULT; ARTICLE; BACTERIAL VIRULENCE; CHEMOPROPHYLAXIS; COLOMBIAN; DISEASE COURSE; DNA METHYLATION; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; PYROSEQUENCING; STOMACH BIOPSY; STOMACH LESION; ADENOCARCINOMA; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FORECASTING; GASTROINTESTINAL ENDOSCOPY; GENETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA; STOMACH NEOPLASMS;

ADENOCARCINOMA; ADULT; ANTI-BACTERIAL AGENTS; BIOMARKERS, TUMOR; CHEMOPREVENTION; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; DOUBLE-BLIND METHOD; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FORECASTING; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 84942881913     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0388     Document Type: Article

References (50)

1. International Agency for Research on Cancer [home page on the internet]. Lyon, France: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, [updated 2015 Jun 7; cited 2015 Jul 6]. Cancer Incidence and Mortality Worldwide. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
2. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Immunol Scand 1965;64:31-49.
4. Correa P. Human Gastric Carcinogenesis: A multistep and multifactorial process-First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
5. Correa P. The gastric precancerous process. Cancer Surveys 1983;2:437-50.
6. Ihamaki T, Sipponen P, Varis K, Kekki M, Siurala M. Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol Suppl 1991;186:16-23.
7. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands. Gastroenterology 2008;134: 945-52.
8. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109: 138-43.
9. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513:202-9.
10. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502-6.
11. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-95.
12. Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006;12:3216-21.
13. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010;70: 1430-40.
14. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006;55:463-8.
15. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8.
16. Mera R, FonthamET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005;54:1536-40.
17. Garvey W, Fathi A, Bigelow F. Modified Steiner for the demonstration of spirochetes. J Histotechnol 1985;8:15-7.
18. Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, Sobota RS, et al. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A 2014;111:1455-60.
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20: 1161-81.
20. Schneider BG, Piazuelo MB, Sicinschi LA, Mera R, Peng DF, Roa JC, et al. Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae. Epigenetics 2013;8:1-9.
21. Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 2010;127:2588-97.
22. Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res 2011;71:7187-97.
23. Oh JH, Rhyu MG, Jung SH, Choi SW, Kim SI, Hong SJ. Slow overmethylation of housekeeping genes in the body mucosa is associated with the risk for gastric cancer. Cancer Prev Res 2014;7:585-95.
24. Asada K, Nakajima T, Shimazu T, Yamamichi N, Maekita T, Yokoi C, et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study. Gut 2015;64:388-96.
25. Atherton JC, Sharp PM, Cover TL, Gonzalez-Valencia G, Peek RM Jr., Thompson SA, et al. Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol 1999;39: 211-8.
26. Sicinschi LA, Correa P, Peek RMJ, Camargo MC, Delgado A, Piazuelo MB, et al. Helicobacter pylori genotyping and sequencing using paraffin-embedded biopsies from residents of Colombian areas with contrasting gastric cancer risks. Helicobacter 2008;13:135-45.
27. Li Z, Chim JC, Yang M, Ye J, Wong BC, Qiao L. Role of PCDH10 and its hypermethylation in human gastric cancer. Biochim Biophys Acta 2012;1823:298-305.
28. Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2009;136: 640-51.e1.
29. Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res 2008;14:6264-9.
30. Bell SM, Schreiner CM, Wert SE, Mucenski ML, Scott WJ, Whitsett JA. Rspondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development (Cambridge, England) 2008;135:1049-58.
31. Zhong J, Chen S, XueM, Du Q, Cai J, Jin H, et al. ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI3K andMAPKsignaling pathways in gastric cancer.BMC Cancer 2012;12: 290.
32. Zanner R, Gratzl M, Prinz C. Expression of the endocytic proteins dynamin and amphiphysin in rat gastric enterochromaffin-like cells. J Cell Sci 2004;117:2369-76.
33. Breiderhoff T, Christiansen GB, Pallesen LT, Vaegter C, Nykjaer A, Holm MM, et al. Sortilin-related receptor SORCS3 is a postsynaptic modulator of synaptic depression and fear extinction. PLoS ONE 2013;8:e75006.
34. Nanjo S, Asada K, Yamashita S, Nakajima T, Nakazawa K, Maekita T, et al. Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection. Gastric Cancer 2012;15:382-8.
35. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012;143:550-63.
36. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40.
37. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983;220:1055-7.
38. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005;102:10604-9.
39. Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A 2012;109:10522-7.
40. Rakyan VK, Down TA, Maslau S, Andrew T, Yang TP, Beyan H, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 2010;20:434-9.
41. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genomewide methylation profiles reveal quantitative views of human aging rates. Molecular Cell 2013;49:359-67.
42. Bocklandt S, Lin W, Sehl ME, Sanchez FJ, Sinsheimer JS, Horvath S, et al. Epigenetic predictor of age. PLoS ONE 2011;6:e14821.
43. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013;14:R115.
44. Florath I, Butterbach K, Muller H, Bewerunge-Hudler M, Brenner H. Crosssectional and longitudinal changes in DNA methylation with age: An epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet 2014;23:1186-201.
45. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissuespecific epigenetic variation across brain and blood. Genome Biol 2012;13: R43.
46. Thompson RF, Atzmon G, Gheorghe C, Liang HQ, Lowes C, Greally JM, et al. Tissue-specific dysregulation of DNAmethylation in aging. Aging Cell 2010;9:506-18.
47. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 2010;20:440-6.
48. Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015;16:25.
49. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M, et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci U S A 2014;111:15538-43.
50. Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011;7:e1002300.